Hypertension

The FDA on Oct. 15 issued a warning letter to India-based Torrent Pharmaceuticals, targeting the drug company as one of the primary contributors to the onslaught of BP drug recalls in the past year.

A study of thousands of individuals in Canada suggests the use of angiotensin receptor blockers—as opposed to ACE inhibitors—could be linked to an increased risk of suicide and poor mental health.

Consumer watchdog group U.S. PIRG is criticizing the FDA for “missing their timeline” to review potentially carcinogenic blood pressure medications like losartan, valsartan and irbesartan, arguing the agency needs to step up its efforts to ensure pharmaceutical companies are distributing safe drugs.

The New York City Department of Health and Mental Hygiene has expanded its Health Bucks program to allow pharmacists to “prescribe” produce to low-income residents with high blood pressure.

Torrent Pharmaceuticals Limited is the latest drug company to issue a recall of losartan potassium, a popular blood pressure drug that’s been under scrutiny for more than a year for containing probable human carcinogens.

Research presented at the American Heart Association’s Hypertension 2019 Scientific Sessions this month suggests having high blood pressure speeds up cognitive decline in middle-aged and older adults—but treating the condition can reverse that possibility.

Research out of UT Southwestern Medical Center in Dallas suggests at-home blood pressure monitoring is a more accurate approach to CV risk prediction in black patients.

Nearly two-thirds of American medical students have higher-than-average blood pressure, according to research presented at the American Heart Association’s Hypertension 2019 Scientific Sessions.

Native Hawaiians who struggled to control their high blood pressure and type 2 diabetes benefited greatly from a six-month hula dancing program, researchers reported at the American Heart Association’s Hypertension 2019 Scientific Sessions.

Preliminary research presented at the American Heart Association’s Hypertension 2019 Scientific Sessions this week suggests gut bacteria could be an indicator of whether someone with high blood pressure also suffers from depression.

Orchestra BioMed, Inc., on Sept. 4 announced it received CE mark approval for its Moderato implantable pulse generation system, which delivers the company’s trademarked cardiac neuromodulation therapy to patients while simultaneously acting as a pacemaker.

Research presented this month at the ESC Congress in Paris suggests that getting a yearly influenza shot could greatly cut hypertensive patients’ risk of dying during flu season.